General information | TED patients (n = 15) | Controls (n = 15) | P value |
---|---|---|---|
Age—yr | 47.9 ± 10.3 | 46.5 ± 9.8 | 0.083 |
Gender—no. (%) Male Female | 7 (46.7%) 8 (53.3%) | 6 (40.0%) 9 (60.0%) | 0.713 |
Body mass index (kg/m2) | 25.3 ± 3.2 | 26.4 ± 3.8 | 0.091 |
Total triiodothyronine (µM/l) | 1.9 ± 0.2 | 2.0 ± 0.4 | 0.098 |
Total thyroxine (µM/l) | 96.9 ± 11.9 | 93.8 ± 14.3 | 0.074 |
Thyroid-stimulating hormone (mU/l) | 1.8 ± 0.4 | 1.5 ± 0.2 | 0.078 |
Smoking status Currently smoke | 4 (26.7%) | 5 (33.3%) | 0.628 |
Previously smoked Never smoked | 7 (46.7%) 4 (26.7%) | 3 (20.0%) 7 (46.7%) | |
TSH-receptor-antibody (mU/L) | 43 ± 3.8 | 1.5 ± 0.3 | 0.001 |
Free triiodothyronine (pmol/L) | 15 ± 1.9 | 3.4 ± 0.5 | 0.008 |
Free thyroxine (pmol/L) | 27.8 ± 0.4 | 14.7 ± 2.3 | 0.006 |
Type of autoimmune thyroid disorder | |||
Hyperthyroidism | 10/15 | ||
Hypothyroidism | 2/15 | ||
Hashimoto’s thyroiditis | 2/15 | ||
Thyroid cancer | 1/15 |